201 related articles for article (PubMed ID: 25120271)
21. EGFR signaling suppresses osteoblast differentiation and inhibits expression of master osteoblastic transcription factors Runx2 and Osterix.
Zhu J; Shimizu E; Zhang X; Partridge NC; Qin L
J Cell Biochem; 2011 Jul; 112(7):1749-60. PubMed ID: 21381079
[TBL] [Abstract][Full Text] [Related]
22. Comparative analysis of osteoblast gene expression profiles and Runx2 genomic occupancy of mouse and human osteoblasts in vitro.
Tarkkonen K; Hieta R; Kytölä V; Nykter M; Kiviranta R
Gene; 2017 Aug; 626():119-131. PubMed ID: 28502869
[TBL] [Abstract][Full Text] [Related]
23. Activation of peroxisome proliferator-activated receptor-gamma inhibits the Runx2-mediated transcription of osteocalcin in osteoblasts.
Jeon MJ; Kim JA; Kwon SH; Kim SW; Park KS; Park SW; Kim SY; Shin CS
J Biol Chem; 2003 Jun; 278(26):23270-7. PubMed ID: 12704187
[TBL] [Abstract][Full Text] [Related]
24. Menin is required for bone morphogenetic protein 2- and transforming growth factor beta-regulated osteoblastic differentiation through interaction with Smads and Runx2.
Sowa H; Kaji H; Hendy GN; Canaff L; Komori T; Sugimoto T; Chihara K
J Biol Chem; 2004 Sep; 279(39):40267-75. PubMed ID: 15150273
[TBL] [Abstract][Full Text] [Related]
25. SP7 inhibits osteoblast differentiation at a late stage in mice.
Yoshida CA; Komori H; Maruyama Z; Miyazaki T; Kawasaki K; Furuichi T; Fukuyama R; Mori M; Yamana K; Nakamura K; Liu W; Toyosawa S; Moriishi T; Kawaguchi H; Takada K; Komori T
PLoS One; 2012; 7(3):e32364. PubMed ID: 22396760
[TBL] [Abstract][Full Text] [Related]
26. Progressive recruitment of Runx2 to genomic targets despite decreasing expression during osteoblast differentiation.
Pregizer S; Baniwal SK; Yan X; Borok Z; Frenkel B
J Cell Biochem; 2008 Nov; 105(4):965-70. PubMed ID: 18821584
[TBL] [Abstract][Full Text] [Related]
27. Characterization of the upstream mouse Cbfa1/Runx2 promoter.
Xiao ZS; Liu SG; Hinson TK; Quarles LD
J Cell Biochem; 2001; 82(4):647-59. PubMed ID: 11500942
[TBL] [Abstract][Full Text] [Related]
28. Genomic occupancy of Runx2 with global expression profiling identifies a novel dimension to control of osteoblastogenesis.
Wu H; Whitfield TW; Gordon JA; Dobson JR; Tai PW; van Wijnen AJ; Stein JL; Stein GS; Lian JB
Genome Biol; 2014 Mar; 15(3):R52. PubMed ID: 24655370
[TBL] [Abstract][Full Text] [Related]
29. Nrf2 negatively regulates osteoblast differentiation via interfering with Runx2-dependent transcriptional activation.
Hinoi E; Fujimori S; Wang L; Hojo H; Uno K; Yoneda Y
J Biol Chem; 2006 Jun; 281(26):18015-24. PubMed ID: 16613847
[TBL] [Abstract][Full Text] [Related]
30. Bone-specific transcription factor Runx2 interacts with the 1alpha,25-dihydroxyvitamin D3 receptor to up-regulate rat osteocalcin gene expression in osteoblastic cells.
Paredes R; Arriagada G; Cruzat F; Villagra A; Olate J; Zaidi K; van Wijnen A; Lian JB; Stein GS; Stein JL; Montecino M
Mol Cell Biol; 2004 Oct; 24(20):8847-61. PubMed ID: 15456860
[TBL] [Abstract][Full Text] [Related]
31. Expression of the osteoblast differentiation factor RUNX2 (Cbfa1/AML3/Pebp2alpha A) is inhibited by tumor necrosis factor-alpha.
Gilbert L; He X; Farmer P; Rubin J; Drissi H; van Wijnen AJ; Lian JB; Stein GS; Nanes MS
J Biol Chem; 2002 Jan; 277(4):2695-701. PubMed ID: 11723115
[TBL] [Abstract][Full Text] [Related]
32. Histone demethylase Utx regulates differentiation and mineralization in osteoblasts.
Yang D; Okamura H; Teramachi J; Haneji T
J Cell Biochem; 2015 Nov; 116(11):2628-36. PubMed ID: 25920016
[TBL] [Abstract][Full Text] [Related]
33. Cooperative interactions between activating transcription factor 4 and Runx2/Cbfa1 stimulate osteoblast-specific osteocalcin gene expression.
Xiao G; Jiang D; Ge C; Zhao Z; Lai Y; Boules H; Phimphilai M; Yang X; Karsenty G; Franceschi RT
J Biol Chem; 2005 Sep; 280(35):30689-96. PubMed ID: 16000305
[TBL] [Abstract][Full Text] [Related]
34. HOXA10 controls osteoblastogenesis by directly activating bone regulatory and phenotypic genes.
Hassan MQ; Tare R; Lee SH; Mandeville M; Weiner B; Montecino M; van Wijnen AJ; Stein JL; Stein GS; Lian JB
Mol Cell Biol; 2007 May; 27(9):3337-52. PubMed ID: 17325044
[TBL] [Abstract][Full Text] [Related]
35. Dose-dependent effects of Runx2 on bone development.
Zhang S; Xiao Z; Luo J; He N; Mahlios J; Quarles LD
J Bone Miner Res; 2009 Nov; 24(11):1889-904. PubMed ID: 19419310
[TBL] [Abstract][Full Text] [Related]
36. Orphan nuclear receptor chicken ovalbumin upstream promoter-transcription factor II (COUP-TFII) protein negatively regulates bone morphogenetic protein 2-induced osteoblast differentiation through suppressing runt-related gene 2 (Runx2) activity.
Lee KN; Jang WG; Kim EJ; Oh SH; Son HJ; Kim SH; Franceschi R; Zhang XK; Lee SE; Koh JT
J Biol Chem; 2012 Jun; 287(23):18888-99. PubMed ID: 22493443
[TBL] [Abstract][Full Text] [Related]
37. O-GlcNAc modification of the runt-related transcription factor 2 (Runx2) links osteogenesis and nutrient metabolism in bone marrow mesenchymal stem cells.
Nagel AK; Ball LE
Mol Cell Proteomics; 2014 Dec; 13(12):3381-95. PubMed ID: 25187572
[TBL] [Abstract][Full Text] [Related]
38. Sp7 and Runx2 molecular complex synergistically regulate expression of target genes.
Rashid H; Ma C; Chen H; Wang H; Hassan MQ; Sinha K; de Crombrugghe B; Javed A
Connect Tissue Res; 2014 Aug; 55 Suppl 1(0 1):83-7. PubMed ID: 25158187
[TBL] [Abstract][Full Text] [Related]
39. SWI/SNF chromatin remodeling complex is obligatory for BMP2-induced, Runx2-dependent skeletal gene expression that controls osteoblast differentiation.
Young DW; Pratap J; Javed A; Weiner B; Ohkawa Y; van Wijnen A; Montecino M; Stein GS; Stein JL; Imbalzano AN; Lian JB
J Cell Biochem; 2005 Mar; 94(4):720-30. PubMed ID: 15565649
[TBL] [Abstract][Full Text] [Related]
40. The vitamin D receptor, Runx2, and the Notch signaling pathway cooperate in the transcriptional regulation of osteopontin.
Shen Q; Christakos S
J Biol Chem; 2005 Dec; 280(49):40589-98. PubMed ID: 16195230
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
